Decreased Expression of the FOXO3a Gene Is Associated with Poor Prognosis in Primary Gastric Adenocarcinoma Patients

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Yang, Xiao bo ^a,b   Zhao, Jing jing ^a   Huang, Chun yu ^a   Wang, Qi jing ^a   Pan, Ke ^a   Wang, Dan dan ^a   Pan, Qiu zhong ^a   Jiang, Shan shan ^a   Lv, Lin ^a   Gao, Xiang ^b   Chen, Huang wei ^b   Yao, Jia yin ^b   Zhi, Min ^b   Xia, Jian chuan ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR FKHRL1; FORKHEAD TRANSCRIPTION FACTOR; FOXO3 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; FOXO3A GENE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH ADENOCARCINOMA; TUMOR INVASION; TUMOR VOLUME; WESTERN BLOTTING; ADENOCARCINOMA; GENE EXPRESSION REGULATION; KAPLAN MEIER METHOD; METABOLISM; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; STOMACH NEOPLASMS;

ADENOCARCINOMA; BLOTTING, WESTERN; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS;

EID: 84886010733     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078158     Document Type: Article

References (33)

1. Caruso RA, Bellocco R, Pagano M, Bertoli G, Rigoli L, et al. (2002) Prognostic value of intratumoral neutrophils in advanced gastric carcinoma in a high-risk area in northern Italy. Mod Pathol 15: 831-837.
2. Zhang B, Rong G, Wei H, Zhang M, Bi J, et al. (2008) The prevalence of Th17 cells in patients with gastric cancer. Biochem Biophys Res Commun 374: 533-537.
3. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
4. Ma H, Weng D, Chen Y, Huang W, Pan K, et al. (2010) Extensive analysis of D7S486 in primary gastric cancer supports TESTIN as a candidate tumor suppressor gene. Mol Cancer 9: 190.
5. Zhao JJ, Pan K, Wang W, Chen JG, Wu YH, et al. (2012) The prognostic value of tumor-infiltrating neutrophils in gastric adenocarcinoma after resection. PLoS One 7: e33655.
6. Chen CN, Lin JJ, Chen JJ, Lee PH, Yang CY, et al. (2005) Gene expression profile predicts patient survival of gastric cancer after surgical resection. J Clin Oncol 23: 7286-7295.
7. Yasui W, Oue N, Aung PP, Matsumura S, Shutoh M, et al. (2005) Molecular-pathological prognostic factors of gastric cancer: a review. Gastric Cancer 8: 86-94.
8. Lee HS, Cho SB, Lee HE, Kim MA, Kim JH, et al. (2007) Protein expression profiling and molecular classification of gastric cancer by the tissue array method. Clin Cancer Res 13: 4154-4163.
9. Oue N, Hamai Y, Mitani Y, Matsumura S, Oshimo Y, et al. (2004) Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression. Cancer Res 64: 2397-2405.
10. Hippo Y, Taniguchi H, Tsutsumi S, Machida N, Chong JM, et al. (2002) Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res 62: 233-240.
11. Yasui W, Oue N, Sentani K, Sakamoto N, Motoshita J, (2009) Transcriptome dissection of gastric cancer: identification of novel diagnostic and therapeutic targets from pathology specimens. Pathol Int 59: 121-136.
12. Calnan DR, Brunet A, (2008) The FoxO code. Oncogene 27: 2276-2288.
13. Partridge L, Brüning JC, (2008) Forkhead transcription factors and ageing. Oncogene 27: 2351-2363.
14. Huang H, Tindall DJ, (2006) FOXO factors: a matter of life and death. Future Oncol 2: 83-89.
15. Karger S, Weidinger C, Krause K, Sheu SY, Aigner T, et al. (2009) FOXO3a: a novel player in thyroid carcinogenesis? Endocr Relat Cancer16: 189-199.
16. Anderson MJ, Viars CS, Czekay S, Cavenee WK, Arden KC, (1998) Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily. Genomics 47: 187-199.
17. Galili N, Davis RJ, Fredericks WJ, Mukhopadhyay S, Rauscher FJ, et al. (1993) Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nat Genet 5: 230-235.
18. Jacobs FM, van der Heide LP, Wijchers PJ, Burbach JP, Hoekman MF, et al. (2003) FOXO6, a novel member of the FOXO class of transcription factors with distinct shuttling dynamics. J Biol Chem 278: 35959-35967.
19. Accili D, Arden KC, (2004) FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 117: 421-426.
20. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, et al. (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868.
21. Brunet A, Park J, Tran H, Hu LS, Hemmings BA, et al. (2001) Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol Cell Biol 21: 952-965.
22. Paik JH, Kollipara R, Chu G, Ji H, Xiao Y, et al. (2007) FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 128: 309-323.
23. Zigrino P, Löffek S, Mauch C, (2005) Tumor-stroma interactions: their role in the control of tumor cell invasion. Biochimie 87: 321-328.
24. Arden KC, (2006) Multiple roles of FOXO transcription factors in mammalian cells point to multiple roles in cancer. Exp Gerontol 41: 709-717.
25. Greer EL, Brunet A, (2005) FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 24: 7410-7425.
26. Potente M, Urbich C, Sasaki K, Hofmann WK, Heeschen C, et al. (2005) Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. J Clin Invest 115: 2382-92.
27. Hu MC, Lee DF, Xia W, Golfman LS, Ou-Yang F, et al. (2004) IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117: 225-237.
28. Yang JY, Zong CS, Xia W, Yamaguchi H, Ding Q, et al. (2008) ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation. Nat Cell Biol 10: 138-148.
29. Wang W, Lv L, Pan K, Zhang Y, Zhao JJ, et al. (2011) Reduced expression of transcription factor AP-2α is associated with gastric adenocarcinoma prognosis. PLoS One 6: e24897.
30. Yang JY, Zong CS, Xia WY, Yamaguchi H, Ding QQ, et al. (2008) ERK promotes tumorigenesis by inhibiting FOXO3a via MCM2-mediated degradation. Nature Cell Biology 10: 370-370.
31. Zou Y, Tsai WB, Cheng CJ, Hsu C, Chung YM, et al. (2008) Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis. Breast Cancer Res 10: R21.
32. Habashy HO, Rakha EA, Aleskandarany M, Ahmed MA, Green AR, et al. (2011) FOXO3a nuclear localisation is associated with good prognosis in luminal-like breast cancer. Breast Cancer Res Treat 129: 11-21.
33. Shukla S, Shukla M, Maclennan GT, Fu P, Gupta S, (2009) Deregulation of FOXO3A during prostate cancer progression. Int J Oncol 34: 1613-1620.